Madrigal Pharmaceuticals Inc (MDGL) — Cash Flow Reinvestment Rate
Madrigal Pharmaceuticals Inc (MDGL) has a Cash Flow Reinvestment Rate of 2.60x as of September 2025, reinvesting $207.85 Million (capex $857.00K plus investments $-207.00 Million) from operating cash flow of $79.85 Million. Check how high is Madrigal Pharmaceuticals Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Madrigal Pharmaceuticals Inc Cash Flow Reinvestment Rate (2007–2007)
Historical reinvestment intensity for Madrigal Pharmaceuticals Inc across 1 annual periods. Explore cash flow to debt ratio of Madrigal Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Madrigal Pharmaceuticals Inc (2007–2007)
Year-by-year capital reinvestment analysis for Madrigal Pharmaceuticals Inc. For live market cap and broader valuation context, see Madrigal Pharmaceuticals Inc market cap and net worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2007 | 0.09x | $2.35 Million | $27.22 Million | $2.35 Million | — |